The association between vitamin E intake and remnant cholesterol, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in US adults: a cross-sectional study.
Journal
Lipids in health and disease
ISSN: 1476-511X
Titre abrégé: Lipids Health Dis
Pays: England
ID NLM: 101147696
Informations de publication
Date de publication:
01 Oct 2024
01 Oct 2024
Historique:
received:
08
08
2024
accepted:
19
09
2024
medline:
2
10
2024
pubmed:
2
10
2024
entrez:
1
10
2024
Statut:
epublish
Résumé
Blood lipid profiles are associated with various nutritional elements and dietary factors. This study aimed to explore the association between total dietary vitamin E intake and remnant cholesterol (RC), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) using data from the National Health and Nutrition Examination Survey (NHANES). A cross-sectional analysis was conducted using NHANES 2007-2018 data. A total of 8,639 eligible participants (45.58% men and 54.42% women) with an average age of 46.12 ± 16.65 years were included in this study. Weighted multivariate linear regression and subgroup analyses were used to examine the association between vitamin E intake and RC, TC, HDL-C, and LDL-C. Smooth curve fitting was used to explore potential non-linear associations. After adjusting for other covariates, multivariate linear regression analysis showed that higher vitamin E intake was negatively associated with plasma RC (β = -0.22, 95% CI: -0.27, -0.16), TC (β = -0.33, 95% CI: -0.51, -0.16), LDL-C (β = -0.25, 95% [confidence interval] CI: -0.40, -0.10) and positively associated with HDL-C (β = 0.13, 95% CI: 0.07, 0.20) in US adults. Subgroup analysis indicated that age may influence the association between vitamin E intake and RC. At the same time, gender may also affect the association between vitamin E intake and HDL-C. Higher vitamin E intake was negatively associated with plasma RC, TC, LDL-C and positively associated with HDL-C.
Sections du résumé
BACKGROUND
BACKGROUND
Blood lipid profiles are associated with various nutritional elements and dietary factors. This study aimed to explore the association between total dietary vitamin E intake and remnant cholesterol (RC), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) using data from the National Health and Nutrition Examination Survey (NHANES).
METHODS
METHODS
A cross-sectional analysis was conducted using NHANES 2007-2018 data. A total of 8,639 eligible participants (45.58% men and 54.42% women) with an average age of 46.12 ± 16.65 years were included in this study. Weighted multivariate linear regression and subgroup analyses were used to examine the association between vitamin E intake and RC, TC, HDL-C, and LDL-C. Smooth curve fitting was used to explore potential non-linear associations.
RESULTS
RESULTS
After adjusting for other covariates, multivariate linear regression analysis showed that higher vitamin E intake was negatively associated with plasma RC (β = -0.22, 95% CI: -0.27, -0.16), TC (β = -0.33, 95% CI: -0.51, -0.16), LDL-C (β = -0.25, 95% [confidence interval] CI: -0.40, -0.10) and positively associated with HDL-C (β = 0.13, 95% CI: 0.07, 0.20) in US adults. Subgroup analysis indicated that age may influence the association between vitamin E intake and RC. At the same time, gender may also affect the association between vitamin E intake and HDL-C.
CONCLUSION
CONCLUSIONS
Higher vitamin E intake was negatively associated with plasma RC, TC, LDL-C and positively associated with HDL-C.
Identifiants
pubmed: 39354564
doi: 10.1186/s12944-024-02313-8
pii: 10.1186/s12944-024-02313-8
doi:
Substances chimiques
Vitamin E
1406-18-4
Cholesterol, HDL
0
Cholesterol, LDL
0
Cholesterol
97C5T2UQ7J
Triglycerides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
325Subventions
Organisme : National Natural Science Foundation of China
ID : 82172478
Organisme : the Young Taishan Scholars Program
ID : tsqn201909190
Organisme : Shandong Higher Education Young Science and Technology Support Program
ID : 2021KJ048
Organisme : Innovation Fund of National Orthopedics and Sports Rehabilitation Clinical Medicine Research Center
ID : 2021-NCRC-CXJJ-ZH-02
Informations de copyright
© 2024. The Author(s).
Références
Global regional et al. and national comparative risk assessment of 84 behaviournvironmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1923–1994.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 139(25):e1046-e1081.
Quispe R, Martin SS, Michos ED, Lamba I, Blumenthal RS, Saeed A, Lima J, Puri R, Nomura S, Tsai M, et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. Eur Heart J. 2021;42(42):4324–32.
doi: 10.1093/eurheartj/ehab432
pubmed: 34293083
pmcid: 8572557
Kim J, Ha J, Jeong C, Lee J, Lim Y, Jo K, Kim MK, Kwon HS, Song KH, Baek KH. Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study. Osteoporos Int. 2023;34(1):119–28.
doi: 10.1007/s00198-022-06571-z
pubmed: 36255473
Zhou X, Weng X, Xu J, Wang W. Correlation between remnant cholesterol and hyperuricemia in American adults. Lipids Health Dis. 2024;23(1):176.
doi: 10.1186/s12944-024-02167-0
pubmed: 38851714
pmcid: 11161976
Lamprea-Montealegre JA, Sharrett AR, Matsushita K, Selvin E, Szklo M, Astor BC. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study. Atherosclerosis. 2014;234(1):42–6.
doi: 10.1016/j.atherosclerosis.2014.02.006
pubmed: 24607852
Varbo A, Nordestgaard BG. Remnant cholesterol and Triglyceride-Rich Lipoproteins in atherosclerosis progression and Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2016;36(11):2133–5.
doi: 10.1161/ATVBAHA.116.308305
pubmed: 27784698
Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626–35.
doi: 10.1016/S0140-6736(14)61177-6
pubmed: 25131982
Li W, Huang Z, Fang W, Wang X, Cai Z, Chen G, Wu W, Chen Z, Wu S, Chen Y. Remnant cholesterol variability and incident ischemic stroke in the General Population. Stroke. 2022;53(6):1934–41.
doi: 10.1161/STROKEAHA.121.037756
pubmed: 35543132
Wadström BN, Pedersen KM, Wulff AB, Nordestgaard BG. Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality. Eur Heart J. 2023;44(16):1432–45.
doi: 10.1093/eurheartj/ehac822
pubmed: 36631967
Evans HM, Bishop KS, ON THE EXISTENCE OF A HITHERTO, UNRECOGNIZED DIETARY FACTOR ESSENTIAL FOR REPRODUCTION. Science. 1922;56(1458):650–1.
doi: 10.1126/science.56.1458.650
pubmed: 17838496
Traber MG. Vitamin E regulatory mechanisms. Annu Rev Nutr. 2007;27:347–62.
doi: 10.1146/annurev.nutr.27.061406.093819
pubmed: 17439363
Jiang Q, Christen S, Shigenaga MK, Ames BN. gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr. 2001;74(6):714–22.
doi: 10.1093/ajcn/74.6.714
pubmed: 11722951
Farina N, Llewellyn D, Isaac M, Tabet N. Vitamin E for Alzheimer’s dementia and mild cognitive impairment. Cochrane Database Syst Rev. 2017;4(4):Cd002854.
pubmed: 28418065
Zuo S, Wang G, Han Q, Xiao H, Avelar Rodriguez HOS, Khani D, Tang V. The effects of tocotrienol supplementation on lipid profile: a meta-analysis of randomized controlled trials. Complement Ther Med. 2020;52:102450.
doi: 10.1016/j.ctim.2020.102450
pubmed: 32951713
Krasinski SD, Russell RM, Otradovec CL, Sadowski JA, Hartz SC, Jacob RA, McGandy RB. Relationship of vitamin A and vitamin E intake to fasting plasma retinol, retinol-binding protein, retinyl esters, carotene, alpha-tocopherol, and cholesterol among elderly people and young adults: increased plasma retinyl esters among vitamin A-supplement users. Am J Clin Nutr. 1989;49(1):112–20.
doi: 10.1093/ajcn/49.1.112
pubmed: 2911996
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
doi: 10.1093/clinchem/18.6.499
pubmed: 4337382
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–88.
doi: 10.1093/eurheartj/ehz455
pubmed: 31504418
Heo JH, Jung HN, Roh E, Han KD, Kang JG, Lee SJ, Ihm SH. Association of remnant cholesterol with risk of dementia: a nationwide population-based cohort study in South Korea. Lancet Healthy Longev. 2024;5(8):e524–33.
doi: 10.1016/S2666-7568(24)00112-0
pubmed: 39068948
Tian Y, Wu Y, Qi M, Song L, Chen B, Wang C, Lu J, Yang Y, Zhang X, Cui J, et al. Associations of remnant cholesterol with cardiovascular and cancer mortality in a nationwide cohort. Sci Bull (Beijing). 2024;69(4):526–34.
doi: 10.1016/j.scib.2023.12.035
pubmed: 38155000
Xiao P, Wang Z, Lu Z, Liu S, Huang C, Xu Y, Tian Y. The association between remnant cholesterol and bone mineral density in US adults: the National Health and Nutrition Examination Survey (NHANES) 2013–2018. Lipids Health Dis. 2024;23(1):148.
doi: 10.1186/s12944-024-02145-6
pubmed: 38762471
pmcid: 11102129
Yao L, Yang P. Relationship between remnant cholesterol and risk of kidney stones in U.S. adults: a 2007–2016 NHANES analysis. Ann Med. 2024;56(1):2319749.
doi: 10.1080/07853890.2024.2319749
pubmed: 38733306
pmcid: 11089921
von Eckardstein A, Nordestgaard BG, Remaley AT, Catapano AL. High-density lipoprotein revisited: biological functions and clinical relevance. Eur Heart J. 2023;44(16):1394–407.
doi: 10.1093/eurheartj/ehac605
Crea F. High-density lipoproteins, lipoprotein(a), and remnant cholesterol: new opportunities for reducing residual cardiovascular risk. Eur Heart J. 2023;44(16):1379–82.
doi: 10.1093/eurheartj/ehad224
pubmed: 37081140
Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000.
doi: 10.1001/jama.2009.1619
pubmed: 19903920
Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) Study. Circulation. 2001;104(10):1108–13.
doi: 10.1161/hc3501.095214
pubmed: 11535564
Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. Framingham Study Jama. 1986;256(20):2835–8.
pubmed: 3773200
Cardner M, Yalcinkaya M, Goetze S, Luca E, Balaz M, Hunjadi M, Hartung J, Shemet A, Kränkel N, Radosavljevic S et al. Structure-function relationships of HDL in diabetes and coronary heart disease. JCI Insight. 2020; 5(1).
Annema W, von Eckardstein A. High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis. Circ J. 2013;77(10):2432–48.
doi: 10.1253/circj.CJ-13-1025
pubmed: 24067275
Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP, Braunwald E, Sammons E, et al. Effects of Anacetrapib in patients with atherosclerotic vascular disease. N Engl J Med. 2017;377(13):1217–27.
doi: 10.1056/NEJMoa1706444
pubmed: 28847206
Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–77.
doi: 10.1093/eurheartj/ehz425
pubmed: 31504439
Chen L, Chen S, Bai X, Su M, He L, Li G, He G, Yang Y, Zhang X, Cui J, et al. Low-density lipoprotein cholesterol, Cardiovascular Disease Risk, and Mortality in China. JAMA Netw Open. 2024;7(7):e2422558.
doi: 10.1001/jamanetworkopen.2024.22558
pubmed: 39023892
pmcid: 11258592
Mattiuzzi C, Sanchis-Gomar F, Lippi G. Worldwide burden of LDL cholesterol: implications in cardiovascular disease. Nutr Metab Cardiovasc Dis. 2020;30(2):241–4.
doi: 10.1016/j.numecd.2019.09.008
pubmed: 31748177
Rodriguez F, Khera A. How low can you go? New evidence supports no lower bound to Low-Density Lipoprotein Cholesterol Level in secondary Prevention. Circulation. 2023;147(16):1204–7.
doi: 10.1161/CIRCULATIONAHA.123.064041
pubmed: 37068134
pmcid: 10281650
Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267–78.
doi: 10.1016/S0140-6736(05)67394-1
pubmed: 16214597
Heidari H, Hajhashemy Z, Saneei P. A meta-analysis of effects of vitamin E supplementation alone and in combination with omega-3 or magnesium on polycystic ovary syndrome. Sci Rep. 2022;12(1):19927.
doi: 10.1038/s41598-022-24467-0
pubmed: 36402830
pmcid: 9675810
Arrol S, Mackness MI, Durrington PN. Vitamin E supplementation increases the resistance of both LDL and HDL to oxidation and increases cholesteryl ester transfer activity. Atherosclerosis. 2000;150(1):129–34.
doi: 10.1016/S0021-9150(99)00353-6
pubmed: 10781643
Kalbfleisch JH, Barboriak JJ, Else BA, Hughes CV, Tristani FE. Alpha-tocopherol supplements and high-density-lipoprotein-cholesterol levels. Br J Nutr. 1986;55(1):71–7.
doi: 10.1079/BJN19860011
pubmed: 3663580
Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res. 2000;87(5):349–54.
doi: 10.1161/01.RES.87.5.349
pubmed: 10969031
Diaz MN, Frei B, Vita JA, Keaney JF. Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337(6):408–16.
doi: 10.1056/NEJM199708073370607
pubmed: 9241131
Hodis HN, Mack WJ, LaBree L, Mahrer PR, Sevanian A, Liu CR, Liu CH, Hwang J, Selzer RH, Azen SP. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the vitamin E atherosclerosis Prevention Study (VEAPS). Circulation. 2002;106(12):1453–9.
doi: 10.1161/01.CIR.0000029092.99946.08
pubmed: 12234947
Costacou T, Levy AP, Miller RG, Snell-Bergeon J, Asleh R, Farbstein D, Fickley CE, Pambianco G, de la Vega R, Evans RW, et al. Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial. Acta Diabetol. 2016;53(2):243–50.
doi: 10.1007/s00592-015-0770-8
pubmed: 26002590
Asleh R, Levy AP. Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with diabetes and the hp 2–2 genotype. Antioxid Redox Signal. 2010;12(2):209–17.
doi: 10.1089/ars.2009.2829
pubmed: 19769483
pmcid: 2821143